These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 3542573

  • 21. Inhibition of thromboxane synthesis and platelet aggregation by pyridine and its derivatives.
    Tai HH, Lee N, Tai CL.
    Adv Prostaglandin Thromboxane Res; 1980; 6():447-52. PubMed ID: 7189951
    [Abstract] [Full Text] [Related]

  • 22. Effects of a specific thromboxane synthetase inhibitor in equine endotoxaemia.
    Semrad SD, Moore JN.
    Res Vet Sci; 1987 Sep; 43(2):137-42. PubMed ID: 3317581
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. CGS 12970: a novel, long acting thromboxane synthetase inhibitor.
    Ambler J, Butler KD, Ku EC, Maguire ED, Smith JR, Wallis RB.
    Br J Pharmacol; 1985 Oct; 86(2):497-504. PubMed ID: 2932197
    [Abstract] [Full Text] [Related]

  • 25. Platelet aggregation in whole blood: the role of thromboxane A2 and adenosine diphosphate.
    Carter AJ, Heptinstall S.
    Thromb Haemost; 1985 Oct 30; 54(3):612-6. PubMed ID: 3937261
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Evidence that prostaglandin endoperoxides can induce platelet aggregation in the absence of thromboxane A2 production.
    Hornby EJ, Skidmore IF.
    Biochem Pharmacol; 1982 Mar 15; 31(6):1158-60. PubMed ID: 7200773
    [No Abstract] [Full Text] [Related]

  • 28. The biochemical pharmacology of thromboxane synthase inhibition in man.
    FitzGerald GA, Reilly IA, Pedersen AK.
    Circulation; 1985 Dec 15; 72(6):1194-201. PubMed ID: 3905048
    [Abstract] [Full Text] [Related]

  • 29. The biological role of thromboxane A2 in the process of hemostasis and thrombosis; pharmacology and perspectives of therapeutical use of thromboxane synthetase inhibitors and receptor PGH2/TXA2 antagonists.
    Radomski M.
    Acta Physiol Pol; 1985 Dec 15; 36(3):153-64. PubMed ID: 3915630
    [Abstract] [Full Text] [Related]

  • 30. [Mechanism of changes in the platelet functional activity caused by low energy laser irradiation].
    Spasov AA, Nedogoda VV, Konan K.
    Biull Eksp Biol Med; 1998 Jul 15; 126(7):45-8. PubMed ID: 9777195
    [No Abstract] [Full Text] [Related]

  • 31. A selective thromboxane synthetase inhibitor blocks the cAMP lowering activity of PGH2.
    Gorman RR, Fitzpatrick FA, Miller OV.
    Biochem Biophys Res Commun; 1977 Nov 07; 79(1):305-13. PubMed ID: 200243
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Imidazo[1,5-a]pyridines: a new class of thromboxane A2 synthetase inhibitors.
    Ford NF, Browne LJ, Campbell T, Gemenden C, Goldstein R, Gude C, Wasley JW.
    J Med Chem; 1985 Feb 07; 28(2):164-70. PubMed ID: 3918169
    [Abstract] [Full Text] [Related]

  • 37. [Highlights of thromboxane synthetase inhibitor research].
    Yu WG, Xu LN.
    Sheng Li Ke Xue Jin Zhan; 1990 Jul 07; 21(3):216-20. PubMed ID: 2244198
    [No Abstract] [Full Text] [Related]

  • 38. [In vitro study of the mechanism of the platelet anti-aggregant action of picotamide (G 137)].
    Berrettini M, De Cunto M, Romanelli A, Volpato I, Orzalesi G, Nenci GG.
    Boll Soc Ital Biol Sper; 1983 Mar 30; 59(3):309-15. PubMed ID: 9704127
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Vasoconstriction with thromboxane A2 induces ulceration of the gastric mucosa.
    Whittle BJ, Kauffman GL, Moncada S.
    Nature; 1981 Jul 30; 292(5822):472-4. PubMed ID: 7195986
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.